510(k) Report

510(k) · Cleared

Cleared

ChestView US

K241620510(k) TraditionalCleared Feb 27, 2025267-day reviewClass II21 CFR 892.2070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gleamer Sas · MYN Analyzer, Medical Image

Cleared on Feb 27, 2025 as substantially equivalent to K213353 (Imagen Technologies, Inc., 2022) after a 267-day review. Its family tree reaches back 3 generations to 2001. 1 later device descends from it.

Decided
Feb 27, 2025
Review
267 days
Class
Class II
Product code
MYN
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to P000041 (2001). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant clearedP000041 · Rapidscreen RS-2000 · Riverain Medical Group · 2001K210666 · Chest-CAD · Imagen Technologies, Inc. · 2021K213353 · Aorta-CAD · Imagen Technologies, Inc. · 2022200020052010201520202025
  1. Root · 3 generations backP000041 Rapidscreen RS-2000Riverain Medical Group · 2001
  2. 2 generations backK210666 Chest-CADImagen Technologies, Inc. · 2021
  3. 1 generation backK213353 Aorta-CADImagen Technologies, Inc. · 2022
  4. This deviceK241620 ChestView USGleamer Sas · 2025
  5. Descendant · cites it directly · 0 of its ownK252486 ChestView US (1.1)Gleamer · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252486ChestView US (1.1)Gleamer · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3P000041Rapidscreen RS-2000Riverain Medical Group2001—
−2K210666Chest-CADImagen Technologies, Inc.2021—
−1K213353Aorta-CADImagen Technologies, Inc.2022—
0 (this device)K241620ChestView USGleamer Sas2025—
+1K252486ChestView US (1.1)Gleamer2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K241620, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MYN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MYN device

  1. #1 K210365 Second Opinionscore 29.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K213353Aorta-CAD
Summary page 5
…21 CFR 892.2070 Product Code MYN Classification Class II 3. Predicate Device Predicate Device Aorta-CAD 510(k) Reference K213353 4. Device Description ChestView US is a radiological Computer-Assisted Detection (CADe) software device intended to analyze…
Imagen Technologies, Inc.2022—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252486ChestView US (1.1)Gleamer20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 2.4 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K252486 (Gleamer, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MYN devices

MYN Analyzer, Medical Image: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · MYN

14in 2025

2007: 52008: 22010: 22011: 12012: 62013: 42014: 32015: 32016: 22017: 32019: 12021: 22022: 52023: 102024: 22025: 142026 (partial year): 7
2007high 14 (2025) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MYN

210in 2025

2022: 273 days median2023: 229 days median2025: 210 days median2026 (partial year): 128 days median
2007high 273 (2022) · low 210 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MYN

No recall names MYN since 2007.

Adverse event reports per year · MYN

2in 2025

2018: 12024: 12025: 2
2007high 2 (2025) · low 0 (2007)2025

MAUDE reports naming product code MYN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075—00
20082—00
20090—00
20102—00
20111—00
20126—00
20134—00
20143—00
20153—00
20162—00
20173—00
20180—01
20191—00
20200—00
20212—00
2022527300
20231022900
20242—01
20251421002
202671280—

What is it indicated for?

ChestView US is a radiological Computer-Assisted Detection (CADe) software device that analyzes frontal and lateral chest radiographs of patients presenting with symptoms (e.g. dyspnea, cough, pain) or suspected for findings related to regions of interest (ROIs) in the lungs, airways, mediastinum/hila and pleural space. The device uses machine learning techniques to identify and produces boxes around the ROIs. The boxes are labeled with one of the…

Read the full statement (129 words)

ChestView US is a radiological Computer-Assisted Detection (CADe) software device that analyzes frontal and lateral chest radiographs of patients presenting with symptoms (e.g. dyspnea, cough, pain) or suspected for findings related to regions of interest (ROIs) in the lungs, airways, mediastinum/hila and pleural space. The device uses machine learning techniques to identify and produces boxes around the ROIs. The boxes are labeled with one of the following radiographic findings : Nodule, Pleural space abnormality, Mediastinum/Hila abnormality, and Consolidation .

ChestView is intended for use as a concurrent reading aid for radiologists and emergency medicine physicians. It does not replace the role of radiologists and emergency medicine physicians or of other diagnostic testing in the standard of care. ChestView is for prescription use only and is indicated for adults only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K241620: ChestView US.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241620

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026